on 28 Dec 2016
Last Applicant/ Owned by
Swedish Orphan Biovitrum AG
12 ch. des Aulx, Plan-les-Ouates, Geneva
, , 1228
Serial Number
UK00916212441 filed on 28th Dec 2016
Registration Number
UK00916212441 registered on
1st May 2017
Correspondent Information
Cooley (UK) LLP
22 Bishopsgate
London,
EC2N 4BQ
Biochemicals, namely, polypeptides, superantigens, biomarkers and antibodies for medical and scientific research; cells, cell extracts and components of cells for medical and scientific research; diagnostic agents for medical and scientific research; diagnostic biomarker reagent for biomarker reagents for medical and scientific research; diagnostic test kits consisting primarily of biomarkers for medical and scientific research; biochemical test kits consisting of assays and reagents for medical and scientific research purposes.
Pharmaceutical and biological preparations; pharmaceutical and biological preparations based on polypeptides, superantigens, biomarkers and antibodies; immunotherapies, pharmaceutical and biological preparations for use in the diagnosis, prevention, management and treatment of immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; therapeutic and diagnostic agents, preparations and substances for use in therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; biochemicals, polypeptides, antibodies, biomarkers and superantigens for use in diagnoses and therapies for immunological, inflammatory, oncological, viral, infectious, neurological, musculoskeletal, respiratory, and dermatological diseases, disorders and conditions; engineered cell therapies for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic test kits consisting primarily of biomarkers for medical purposes; biochemical test kits comprised of assays and reagents for medical, diagnostic and therapeutic purposes.
UK00916212441
Word
Individual